Tenax Therapeutics to Discuss Year-End 2016 Financial Results and Provide Business Update
March 15 2017 - 4:31PM
Business Wire
Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty
pharmaceutical company focused on identifying, developing and
commercializing products for the critical care market, today
announced that the Company will host a conference call and live
audio webcast on Tuesday, March 21, 2017, at 8:30 a.m. ET to
discuss its year-end 2016 financial results and provide a business
update.
To participate in the call, please dial (866) 682-6100
(domestic) or (862) 255-5401 (international). A live webcast of the
call can be accessed under “Events and Presentations” in the
Investors section of the Company’s website at www.tenaxthera.com.
An archived webcast recording will be available on the Tenax
Therapeutics website beginning approximately two hours after the
call.
About Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company
focused on identifying, developing and commercializing products for
the critical care market. The Company owns the North American
rights to develop and commercialize levosimendan, a novel, first in
class calcium sensitizer/K-ATP activator. For more information,
visit www.tenaxthera.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170315006426/en/
Stern Investor Relations, Inc.Will O‘Connor,
212-362-1200will@sternir.com
Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
From Apr 2023 to Apr 2024